RedHill Biopharma reported $4.48M in Selling and Administration Expenses for its fiscal quarter ending in March of 2024.


Selling And Administration Expenses Change Date
Clal Biotechnology ILS 3.31M 513K Dec/2022
Compugen USD 2.38M 12K Jun/2025
Cronos Group USD 15.88M 79K Jun/2025
RedHill Biopharma USD 4.48M 1.52M Mar/2024